Aurobindo Pharma
AUROPHARMA.NS
#2119
Rank
โ‚ฌ7.12 B
Marketcap
12,26ย โ‚ฌ
Share price
-0.54%
Change (1 day)
5.57%
Change (1 year)

Revenue for Aurobindo Pharma (AUROPHARMA.NS)

Revenue in 2024 (TTM): โ‚ฌ3.36 Billion

According to Aurobindo Pharma 's latest financial reports the company's current revenue (TTM ) is โ‚ฌ3.45 Billion. an increase over the revenue in the year 2023 that were of โ‚ฌ3.01 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Aurobindo Pharma from 2012 to 2024

Annual revenue

Year Revenue Change
2024 โ‚ฌ3.48 B15.43%
2023 โ‚ฌ3.01 B7.4%
2022 โ‚ฌ2.81 B0.14%
2021 โ‚ฌ2.80 B4.4%
2020 โ‚ฌ2.68 B-2.4%
2019 โ‚ฌ2.75 B19.47%
2018 โ‚ฌ2.30 B11.2%
2017 โ‚ฌ2.07 B-3.61%
2016 โ‚ฌ2.15 B14.8%
2015 โ‚ฌ1.87 B24.44%
2014 โ‚ฌ1.50 B71.21%
2013 โ‚ฌ0.87 B15.31%
2012 โ‚ฌ0.76 B